Literature DB >> 8269602

Differential cytotoxicity of buthionine sulfoximine to "normal" and transformed human lung fibroblast cells.

X S Wan1, D K St Clair.   

Abstract

Glutathione (GSH) depletion has been studied extensively as a possible means to sensitive tumor cells to radiation treatment and chemotherapy. The present study was undertaken to compare the cytotoxicity of GSH depletion in normal and transformed cells. The results showed that specific inhibition of GSH synthesis by L-buthionine sulfoximine (BSO) caused significantly higher cytotoxicity in "normal" human-lung fibroblast cells than in their transformed counterparts. This finding suggests a possibility that depletion of GSH could be more harmful to normal cells than to transformed and/or tumor cells and that the selective cytotoxicity of BSO to normal cells could limit its potential as an effective sensitizer for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8269602     DOI: 10.1007/bf00686218

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  32 in total

1.  Effect of BSO on the radiation response at low (0-4 Gy) doses.

Authors:  K A Skov; H S MacPhail
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results.

Authors:  P J O'Dwyer; T C Hamilton; R C Young; F P LaCreta; N Carp; K D Tew; K Padavic; R L Comis; R F Ozols
Journal:  J Natl Cancer Inst       Date:  1992-02-19       Impact factor: 13.506

Review 4.  Mammalian cell studies with diamide.

Authors:  J W Harris
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

5.  Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress.

Authors:  J Mårtensson; A Jain; E Stole; W Frayer; P A Auld; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

Authors:  O W Griffith; A Meister
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

7.  Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.

Authors:  L Dusre; E G Mimnaugh; C E Myers; B K Sinha
Journal:  Cancer Res       Date:  1989-02-01       Impact factor: 12.701

8.  Glutathione depletion greatly reduces neocarzinostatin cytotoxicity in Chinese hamster V79 cells.

Authors:  W G DeGraff; A Russo; J B Mitchell
Journal:  J Biol Chem       Date:  1985-07-15       Impact factor: 5.157

9.  In vivo and in vitro mechanisms of drug resistance in a rat mammary carcinoma model.

Authors:  R L Schecter; A Woo; M Duong; G Batist
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

10.  Variation in sensitizing efficiency for SR 2508 in human cells dependent on glutathione content.

Authors:  T L Phillips; J B Mitchell; W de Graff; A Russo; E Glatstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-09       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.